knowledge -WSS

knowledge

author：Wikipedia 2025-09-08 11:05:12 - browse：9269

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly — ruling that the treatment’s ability to slow the cognitive decline in patients outweighed its safety risks.

The unanimous outcome of the daylong advisory panel was the best-case scenario for Lilly, making it likely that the FDA will approve the drug, called donanemab, for a broad population of people diagnosed with mild cognitive impairment due to Alzheimer’s. A decision is expected later this year.

“The benefits outweigh the risks, as long as the risks are being monitored,” said Kathleen Poston, a neurologist at Stanford University and a member of the advisory panel.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Mark Cuban is blaming the wrong people for high drug costs

WSS

Biden administration begins canceling student loan debt for 804,000 borrowers

Biogen’s boardroom scandal saddles CEO with first crisis

House looks to weaken Medicare negotiation

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

International team creates first chimeric human

International team creates first chimeric human

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Supreme Court strikes down use of affirmative action

Judge sides with young activists in first

Sports medicine is finally prioritizing gender equality

Health AI: on the border between health care and tech

After affirmative action ruling, medical educators look to 'holistic review'

An inside look at PIPEs, biotech's buzzy new financing tool

Medical records are filled with copy

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

United colonoscopy coverage change 'may cost lives,' doctors say

How to address the problem of discarded donor organs

explore

RSV vaccines may be linked to small increased risk of developing GBS

International team creates first chimeric human

Patients, digital health players weigh in on FTC's data privacy plan

Change Healthcare cyberattack outage could last weeks

BMS, looking to build heart drug business, turns to AI for diagnosis

Clinical trials giant ICON acquires HumanFirst

Wikipedia

hotspot

explore

hotspot